| Previous Section | Index | Home Page |
17 May 2004 : Column 808W—continued
Hospices
Mr. Wood: To ask the Secretary of State for Health how much of the £12 million announced on 26 December 2003 for palliative care will be available to hospices. [167052]
17 May 2004 : Column 809W
Miss Melanie Johnson: The additional £12 million investment over three years announced by my right hon. Friend the Secretary of State on 26 December 2003 follows on from the commitment in the recent Command Paper "Building on the Best".
This additional money is not intended for hospices. It is to be used to ensure that, by widening the pool of generalist staff, in primary care, in care homes and in hospitals, who are trained in meeting the needs of people nearing the end of their lives, patients—regardless of their diagnosis—will have access to high quality palliative care so that they will be able to be cared for and to die in a place of their choice.
Human Fertilisation and Embryology
Mr. Amess: To ask the Secretary of State for Health how many licensed fertility clinics have had their licences (a) suspended and (b) revoked by the Human Fertilisation and Embryology Authority in each year since 1991. [166910]
Miss Melanie Johnson: The number of licence suspensions and revocations for failure to comply with the provisions of either the Human Fertilisation and Embryology Act 1990, the Human Fertilisation and Embryology Authority's code of practice or the conditions of the establishment's licence, since 1997, are shown in the table.
| Year(40) | Suspension | Revocation |
|---|---|---|
| 1999 | — | 1 |
| 2003 | (41)1 | — |
| 2004 | 1 | — |
(39) Figures do not include licences voluntarily given up by licensed establishments.
(40) No licences were suspended or revoked in the years 1997, 1998, 2000, 2001 and 2002.
(41) Suspension applied only to specified licensed activities, not the whole licence.
Source:
Human Fertilisation and Embryology Authority.
Information for 1991 to 1996 is held on microfilmed records, by licensed establishment, and could be provided only at disproportionate cost.
Intermediate Care
Sandra Gidley: To ask the Secretary of State for Health what percentage of National Service Framework local implementation teams have reported that an intermediate care co-ordinator is in place; and if he will make a statement. [171021]
Dr. Ladyman: This information is not collected centrally.
Milton Keynes and South Midlands Sub-regional Strategy
Mr. Lidington:
To ask the Secretary of State for Health if he will make a statement on proposals for increased funding to growth areas in South-east
17 May 2004 : Column 810W
England, as mentioned in paragraph 97 of the Cross-Government Statement (matters 1, 2, 3, 4) on the Milton Keynes and South Midlands Sub-Regional Strategy. [172171]
Mr. Hutton: The Department has given its backing to providing health service infrastructure to support the development of sustainable growth areas.
As announced to Parliament, on 15 March 2004 the Department has agreed to provide an extra £20 million, per annum, of revenue funding in 2004–05 and 2005–06 to be allocated to primary care trusts (PCTs) and £20 million of capital resources in 2005–06 to be allocated to strategic health authorities.
PCTs within the growth areas were notified of their additional 2004–05 and 2005–06 revenue allocations on 25 March 2004.
The Department has also agreed to give priority to Office of the Deputy Prime Minister growth areas for future local improvement finance trust schemes and to include a growth area adjustment for ODPM growth areas in the next round of PCT allocations.
Morphine Sulphate
Mr. Andrew Turner: To ask the Secretary of State for Health what the target date is for the availability of morphine sulphate by NHS prescription in each primary care trust area; in what areas it is already available; and when guidelines will be published on the prescription of morphine sulphate. [171928]
Ms Rosie Winterton: Morphine sulphate is available on national health service prescription and was prescribed in all primary care trust areas in 2003.
Guidance on the prescribing of morphine sulphate is given in the British National Formulary, a copy of which is supplied to all NHS doctors and pharmacists. Advice on the use of morphine sulphate in specific medical conditions has also been published in the Drug and Therapeutics Bulletins, the MeReC Bulletins and in PRODIGY guidance for primary care, which are widely distributed free of charge to NHS professional staff.
Mumps
Mr. Burstow: To ask the Secretary of State for Health what estimate he has made of the number of teenagers in England who (a) are not inoculated against mumps and (b) have had only one of the two necessary doses. [167428]
Miss Melanie Johnson: The Department does not have data on the number of teenagers who either received only one dose of the measles, mumps and rubella (MMR) vaccine or no doses. Most older children and adolescents will naturally be immune from mumps infection. Seroprevalance data, this is data where antibody levels are measures in blood samples, suggests that around 20 per cent., may be unprotected against mumps.
National Service Frameworks
Mr. Waterson:
To ask the Secretary of State for Health (1) if he will make a statement on progress towards the National Service Framework milestone for
17 May 2004 : Column 811W
general practitioner practices diagnosing, treating and caring for older people with depression and dementia; [170615]
(2) if he will make a statement on progress towards the National Service Framework milestone for protocols across health and social care systems for the care and management of older people with mental health problems; [170616]
(3) if he will make a statement on progress towards the National Service Framework milestone for strategic and operational plans to include the development of an integrated mental health service for older people. [170629]
Dr. Ladyman: The Department is monitoring progress towards the development of protocol driven, joined-up mental health services for older people. This is a "must do" target in the 2003–06 priorities and planning framework.
All of the milestones relating to standard 7 of the national service framework are the responsibility of strategic health authorities to plan for and monitor progress towards, but we would expect the type of service mentioned to be part of an integrated service.
Mr. Waterson: To ask the Secretary of State for Health if he will make a statement on progress towards the National Service Framework milestone for integrated continence services across health and social care systems. [170620]
Dr. Ladyman: The responsibility for implementing this milestone and monitoring progress is the responsibility of strategic health authorities. Monitoring information on progress with this milestone is not collected centrally.
NHS Beds
Mr. Frank Field: To ask the Secretary of State for Health how many NHS beds were available in Birkenhead in each year since 1997; and if he will make a statement. [167646]
Miss Melanie Johnson: Information on the average daily number of beds in acute wards in each national health service trust and England from 1996–97 to 2002–03 is available from the Department's website at www.performance.doh.gov.uk/hospitalactivity/index.htm.
Mr. Hendrick: To ask the Secretary of State for Health how many NHS beds were available in Preston in each year since 1997; and if he will make a statement. [168104]
Miss Melanie Johnson: Information on beds is collected on a provider basis from national health service organisations and the latest data available is for the year 2002–03. Beds data for 2003–04 will be published later this year.
Information about the relevant trusts has been placed in the Library.
| Next Section | Index | Home Page |